Austin, Texas 6/15/2007 8:55:31 PM
News / Business

Speak with other shareholders about: (OTC:GWOH); (OTC:CPNLQ); (OTC:MTPM); (OTC:DPHIQ); (OTC:SHTP)

AUSTIN, TX: June 13, 2007 – Are you looking to speak with  other investors about your favorite stock? Stockwire.com, ranked in the top  5,000 websites in the United    States by Alexa.com/Amazon.com, has created  one of the finest chat programs available for investors. Now you can chat  real-time with like-minded individuals about your favorite stock. Visit  Stockwire.com and click the “Chat Now” button at the top.

Have you ever watched a STOCKUMENTARY? Click the following  link to view your first ever full length STOCKUMENTARY:  http://www.stockwire.com/cdrom/streaming_flash_page.htm .

----------------------------------------------------------

Talk to other GWOH shareholders by clicking the following  link: http://www.stockwire.com
   
  QED STORAGE, INC. (PINKSHEETS: GWOH)
 
  QED Storage, Inc. closed at $.85 Thursday, trading 12,500  shares.
 
  On June 14th, QED Storage, Inc., announced that their  Omni-Manager suite now includes the following anti-virus software:
 
  Kaspersky 6.0 is an anti-virus solution that protects PCs and  laptops against viruses, Trojans, spyware, rootkits and other malicious  programs.
 
  PC World, one of the most widely read computer technology  magazines, recently named Kaspersky 6.0 a 'Best Buy' in a review of leading  anti-virus solutions and one of the '100 Best Products of 2007.' Key features  include scanning and disinfection of archived files, protection from dangerous  macros in Microsoft(R) Office documents and support for Windows Vista(TM) and  64-bit systems.
 
  According to the announcement, the award winning Kaspersky  anti-virus software is now a value added feature to be shipped with its  flagship Omni Manager suite. Omni Manager combines critical security  applications in one hosted service, offering a centralized method for managing  and enforcing organizational security policies, tracking IT assets, and  filtering and monitoring Internet and application usage. The addition of  Kaspersky 6.0 expands on Omni Manager's features and functionality, creating a  compelling value proposition for enterprise departments and workgroups, small  to medium sized businesses, educational institutions and non-profit  organizations.
 
  About QED Storage, Inc. (PINKSHEETS: GWOH)
 
  QED is a Managed Services company providing comprehensive  solutions and services to the Small to Medium Business (SMB), Department Enterprise  Organizations (DEO), Education, and other "not for profit"  organizations. The customer's designated administrator has visibility,  management and control over all Internet-related activities as well as asset  management for hardware and software applications, license tracking and user  application reports.
 
  The QED family of products provide the next generation in  Internet security. It is an 'online' management service which secures laptops  & desktops and enforces policies in real time. The QED product provides the  technology and functionality for administrating assets from computers to  employee productivity. Combining core functionality of Anti Virus, Web  Filtering & Blocking, and Usage & Application Management with  comprehensive reporting, QED enables the central application and enforcement of  usage policies across physical and geographic boundaries. For more information,  please visit the company's web site at www.qedstorage.com.
 
  ----------------------------------------------------------

Talk to other CPNLQ shareholders by clicking the following  link: http://www.stockwire.com
   
  CALPINE CORPORATION (PINKSHEETS: CPNLQ)
 
  Calpine Corporation closed at $3.17 Thursday, trading  3,644,171 shares.
 
  On June 14th, Calpine Corporation announced the promotion of  Melissa Brown to senior vice president of Strategy and Financial Planning and  Analysis. She reports to the chief financial officer Lisa Donahue.
 
  According to the announcement, in her new position, Brown will  offer research and analysis on strategic matters and manage Calpine's Financial  Planning and Analysis group, which provides budgets, short-to mid-term  forecasts, variance analysis and plant-and corporate-level financial metric  analysis. Besides that, she will manage an analytics group, which provides  economic analysis. In March 2006 Brown joined Calpine as the senior vice  president-treasurer and will maintain this role on an interim basis, continuing  to manage the Treasury and Corporate Insurance functions. She commenced her  business career at AES Corporation where she was the manager of Corporate  Financial Analysis. She later joined NRG Energy where she held positions of  increasing responsibility in a variety of groups, including Northeast Region,  Treasury, Australia, Asset Sales, NEO Corporation, Corporate Strategy and  Portfolio Assessment, Latin America and Emerging Markets and attained the  position of executive director of Business Development.
 
  About Calpine Corporation (PINK SHEETS: CPNLQ)
 
  Calpine Corporation is helping meet the needs of an economy  that demands more and cleaner sources of electricity. Founded in 1984, Calpine  is a major U.S. power company, capable of delivering nearly 25,000 megawatts of  clean, cost-effective, reliable and fuel-efficient electricity to customers and  communities in 18 states in the U.S. The company owns, leases and operates  low-carbon, natural gas-fired and renewable geothermal power plants. Using  advanced technologies, Calpine generates electricity in a reliable and  environmentally responsible manner for the customers and communities it serves.  More information about the company can be found at: http://www.calpine.com/ .
 
  ----------------------------------------------------------

Talk to other MTPM shareholders by clicking the following  link: http://www.stockwire.com
   
  MITOPHARM CORPORATION. (PINKSHEETS: MTPM)
 
  Mitopharm Corporation, Inc. closed at $1.84 Thursday, trading  186,073 shares.
 
  Earlier today, MitoPharm Corporation, Inc. released the results  of a research paper where Professor Dr. Robert Ko published additional findings  on the biochemical mechanisms of Schisandrin B, the precursor of (-)  Schisandrin B - a novel discovery by Dr. Ko - which explain the beneficial  effects on Myocardial Ischemia-Reperfusion.
 
  According to the announcement, MitoPharm believes that its  products have the potential to play a significant role in addressing the aging  concerns of the baby boomers, the heart-health and heart-diseases markets, and  the segment of the population that is physically active.
 
  In a research paper entitled "SCHISANDRIN B PROTECTS  MYOCARDIAL ISCHEMIA-REPERFUSION INJURY PARTLY BY INDUCING HSP25 AND HSP70  EXPRESSION IN RATS"; Chiu and Ko; Molecular and Cellular Biochemistry  2004; 266: 139-144, Professor Dr. Robert Ko published additional findings on  the biochemical mechanisms of Schisandrin B, the precursor of (-) Schisandrin B  - a novel discovery by Dr. Ko - which explain the beneficial effects on  Myocardial Ischemia-Reperfusion.
 
  Since the publication of this finding, Dr. Ko has identified  an isomer of Schisandrin B, (-) Schisandrin B - a novel discovery - which  possesses a more potent pharmacological profile than that of Schisandrin B.  Patented use of this newly discovered compound, (-) Schisandrin B, for the  prevention and treatment of Ischemic Heart Disease has been applied for with  the US Patent and Trademark Office.
 
  For a copy of this research report, please contact the  publisher, Molecular and Cellular Biochemistry.
 
  About Mitopharm Corporation, Inc. (PINKSHEETS: MTPM)
 
  MitoPharm Corporation is a biotechnology company in the  research & development, marketing and sale of drugs, dietary supplements,  and functional beverages. The initial products are based on a newly discovered  compound (the "Compound") that is the result of over 15 years of  research and development by one of its founding shareholders, the Hong Kong  University of Science and Technology ("HKUST"). MitoPharm believes  that its products have the potential to play a significant role in addressing  the aging concerns of the baby boomers, the heart-health and heart-diseases  markets, and the segment of the population that is physically active.  www.mitopharm.com
 
  ----------------------------------------------------------

Talk to other DPHIQ shareholders by clicking the following  link: http://www.stockwire.com
   
  DELPHI CORPORATION (PINKSHEETS: DPHIQ)
 
  Delphi Corporation closed at $2.79 Friday, trading 15,019,516  shares.
 
  On June 13th, it was reported that a Statement of Ownership  (SC 13D/A) of Delphi Corporation had been filed by Highland Capital Management  LP.
 
  About Delphi Corp. (PINK SHEETS: DPHIQ
 
  Delphi is a leading global supplier of mobile electronics and  transportation systems, including powertrain, safety, steering, thermal, and  controls & security systems, electrical/electronic architecture, and in-car  entertainment technologies. Engineered to meet and exceed the rigorous  standards of the automotive industry, Delphi technology is also found in  computing, communications, consumer electronics, energy and medical  applications. Headquartered in Troy, Mich., Delphi has approximately 171,000  employees and operates 159 wholly owned manufacturing sites in 36 countries  with sales of $26.4 billion in 2006. More information about the company can be  found on its website at: www.delphi.com.
 
  ----------------------------------------------------------

Talk to other SHTP shareholders by clicking the following  link: http://www.stockwire.com
   
  SHOTPAK, INC. (PINKSHEETS: SHTP)
 
  Shotpak, Inc. closed at $.48 Thursday, trading 4,364,089  shares.
 
  On June 13th, Shotpak, Inc. announced today that it has become  publicly traded on the Pink Sheets LLC under the symbol SHTP.PK. The public  should note that the symbol SHPK.PK is inactive and that SHTP.PK is the correct  symbol.
 
  According to the announcement, Shotpak closed on Monday on a  reverse merger with listed company Exclusive Cruises and Tours, Inc., which  formerly traded under the symbol XCLU.PK.
 
  About Shotpak, Inc. (PINKSHEETS: SHTP)
 
  Shotpaks were launched by the Company in 2004 and have  revolutionized the Ready To Drink (RTD) alcohol beverage industry. Shotpaks  consist of 4 Premium Vodka flavored drinks and premium distilled spirits.  Shotpak is quickly gaining national attention in the rapidly emerging $100  billion plus alcohol beverage industry by being the first to introduce single  shot (50ml) premium vodka flavored shots and award winning premium straight  spirits. Shotpaks are packaged in single serving lightweight break resistant  recyclable plastic pouches. Shotpaks are ideal for camping, boating, golfing,  concerts, sporting events or for anyone on the go. Shotpak has begun a national  rollout through strategic distribution channels and is expected to be available  to its consumer targets in all US markets. For more information about Shotpak,  Inc. please visit www.shotpakinc.com.
 
  ----------------------------------------------------------

As a trader, a very intelligent place to put your money, is  where the money is flowing into. These are the kind of trades that you want to  get into.

As the saying goes...follow the money!

To see the complete Movers & Shakers Blog go to:  http://www.stockwire.com .

About Stockwire:
  Stockwire is a company that is pioneering a new way to  research companies before you invest them. It's called a Stockumentary. A  Stockumentary is a documentary on a publicly traded company. Imagine a Dateline  NBC segment, but on a publicly traded company. We are the first company to ever  bring this type of quality research to investors in this format.

The Stockumentary has video interviews with management,  product demos, video tours of office or factory, research reports, sec filings  and much more. All of this is delivered to investors in high quality video,  either by mail or email.

Stockwire.com is owned by Stockwire Research Group Inc.  (SRGI) and is an independent electronic publication committed to providing our  readers with factual information on selected publicly traded companies.

As detailed below, this publication accepts compensation from  some of the companies from which it features. To the degrees listed herein,  this Newsletter should not be regarded as an independent publication. All  statements and expressions are the sole opinions of the editors and are subject  to change without notice. A profile, description, or other mention of a company  in the Newsletter is neither an offer nor solicitation to buy or sell any  securities mentioned.

While we believe all sources of information to be factual  and reliable, in no way do we represent or guarantee the accuracy thereof, nor  the statements made herein.

We encourage our readers to invest carefully and read the  investor information available at the web sites of the Securities and Exchange  Commission ("SEC") at www.sec.gov and/or the National Association of  Securities Dealers ("NASD") at www.nasd.com. The NASD has published  information on how to invest carefully at its web site.

Readers can review all public filings by companies at the  SEC's EDGAR page. www.sec.gov/edgar.shtml

Stockwire.com is an independent electronic publication  committed to providing our readers with factual information on selected  publicly traded companies. Stockwire.com is not a registered investment advisor  or broker-dealer. All companies are chosen on the basis of certain financial  analysis and other pertinent criteria with a view toward maximizing the upside  potential for investors while minimizing the downside risk, whenever possible.

From time to time SRGI sells shares in the open market it  receives as compensation for coverage of client companies. Since the shares are  received as compensation for services as previously disclosed, and not for  investment purposes, the editors do not view the sale of the shares as  contradictory to any advice delivered in the content. This should be viewed as  a conflict of interest by shareholders or prospective shareholders of the  client companies.

Moreover, as detailed below, this publication accepts  compensation from third party consultants and/or companies which it features on  Stockwire.com. Likewise, Stockwire.com is owned by Stockwire Research Group  Inc. (SRGI). To the degrees enumerated herein, this newsletter and website  should not be regarded as an independent publication.

All statements and expressions are the sole opinions of the  editors and are subject to change without notice. A profile, description, or  other mention of a company on Stockwire.com is neither an offer nor  solicitation to buy or sell any securities mentioned. While we believe all  sources of information to be factual and reliable, in no way do we represent or  guarantee the accuracy thereof, nor the statements made herein.

The editor, members of the editor's family, and/or entities  with which the editor is affiliated aside from Stockwire Research Group Inc.  (SRGI) itself, are forbidden by company policy to own, buy, sell or otherwise  trade stock for their own benefit in the companies who appear in the  publication unless specifically disclosed in the newsletter.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE  DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES  IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS  PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE  COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE  EDITORS OF STOCKWIRE.COM.

We often accept restricted shares of company stock; by SEC  regulations, restricted shares cannot be sold into the market for a period of  at least one year from the time that the shares are issued. In such cases, we  detail in the Disclaimer the specific term of any restrictions. We also receive  compensation in the form of stock options, in which case we receive the right  to buy shares of the stock of the company at issue, at a specified time and a  specified price. In such circumstances, we specify on our Disclaimer the terms  of the options received. On occasion, we also accept free-trading shares in a  company that we cover. However, by policy we generally do not buy or sell any  shares of a company's stock within three trading days after any such company's  profile, commentary, or other company-specific information is disseminated on  Stockwire.com Web site. In cases where we do trade within the three day window,  our volume will never represent more than 5% of the daily volume, thereby  minimizing any effect we could have on the potential price movement.

While our policies as detailed above are designed to  minimize any impact upon our members of a conflict of interest between our  company and our members, each member should be fully aware that such potential  and actual conflicts of interest may well exist due to the compensation  structure detailed herein. For this reason, and because the information  contained on Stockwire.com is updated on a regular basis as circumstances  change, each member is strongly encouraged to periodically review the Profile  Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .

Stockwire Research Group, Inc. .
  512.358.8440 .
  info@stockwire.com .